Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Multiple Myeloma
Multiple Myeloma
Juno strikes deal to join bluebird, Novartis in busy multiple myeloma niche
Fierce Biotech
Sat, 08/6/16 - 01:19 pm
Juno Therapeutics
Bluebird Bio
Novartis
Multiple Myeloma
BCMA
Inside AbbVie’s Plans to Target Multiple Myeloma and Acute Myeloid Leukemia Segments with Venclexta
Market Realist
Mon, 07/11/16 - 10:50 am
AbbVie
Multiple Myeloma
acute myeloid leukemia
Venclexta
Johnson & Johnson Courting Huge Revenue Potential In Multiple Myeloma Space
Seeking Alpha
Tue, 06/7/16 - 11:12 am
JNJ
Multiple Myeloma
daratumumab
ASCO 2016
J&J myeloma drug, in combo regimen, delays worsening of the disease
Yahoo/Reuters
Sun, 06/5/16 - 12:01 pm
JNJ
Multiple Myeloma
Darzalex
Takeda
Velcade
ASCO 2016
Amgen Gets CHMP's Positive Opinion To Extend Indication Of Kyprolis For Relapsed Multiple Myeloma Treatment
Yahoo/Benzinga
Fri, 05/27/16 - 10:43 pm
Amgen
CHMP
Kyprolis
Multiple Myeloma
Janssen's multiple myeloma drug passes muster in Europe
BioPharma Dive
Tue, 05/24/16 - 11:42 pm
Janssen
Multiple Myeloma
Europe
JNJ
Darazalex
Drug makers fuming at ‘overpriced’ values placed on their myeloma drugs
Stat
Mon, 05/16/16 - 03:55 pm
Multiple Myeloma
Amgen
Kyprolis
How Takeda Is Changing The Face Of Myeloma Treatment
Seeking Alpha
Sat, 05/7/16 - 01:19 pm
Takeda
Multiple Myeloma
Ninlaro
Amgen's Kyprolis stands its ground against new J&J, BMS rivals
Fierce Pharma
Wed, 05/4/16 - 09:48 am
Amgen
Kyprolis
JNJ
Bristol-Myers Squibb
Multiple Myeloma
Darzalex
Empliciti
AbbVie
Takeda
Ninlaro
New myeloma meds work better than the old, but they're far too expensive: Report
Fierce Biotech
Tue, 04/12/16 - 03:39 pm
Multiple Myeloma
Bristol-Myers Squibb
Amgen
Takeda
Empliciti
Kyprolis
Ninlaro
Celgene
Revlimid
Amgen balks over meeting to review cost of bone cancer drugs
Stat
Thu, 04/7/16 - 09:46 am
Amgen
drug pricing
Kyprolis
Multiple Myeloma
Amgen launches Kyprolis in the UK for multiple myeloma
BioPharma Dive
Thu, 02/18/16 - 05:48 pm
Amgen
Kyprolis
UK
Multiple Myeloma
Celgene Corporation to Continue Dominating Myeloma Market
Bidness, ETC
Wed, 12/30/15 - 11:14 am
Celgene
Multiple Myeloma
Revlimid
Bristol Myers’s Empliciti Receives FDA Approval
Yahoo/Market Realist
Tue, 12/15/15 - 09:47 am
Bristol-Myers Squibb
Empliciti
FDA
Multiple Myeloma
Bluebird, Celgene See Promise in T Cell Therapy for Multiple Myeloma
TheStreet.com
Sat, 12/5/15 - 12:37 pm
Bluebird Bio
Celgene
t cell therapy
Multiple Myeloma
Can Bristol-Myers Squibb And AbbVie's Empliciti Become a Top Seller?
Motley Fool
Tue, 12/1/15 - 01:18 pm
AbbVie
Bristol-Myers Squibb
Empliciti
Multiple Myeloma
Johnson & Johnson's Latest FDA Approval Could Spell Problems for Amgen
Motley Fool
Wed, 11/25/15 - 01:20 pm
JNJ
FDA
Amgen
Darzalex
daratumumab
Multiple Myeloma
FDA approves 3rd multiple myeloma med of 2015, Takeda's Ninlaro
BioPharma Dive
Mon, 11/23/15 - 01:19 pm
FDA
Takeda
Ninlaro
Multiple Myeloma
Takeda's 'breakthrough' Velcade heir wins early FDA approval in myeloma
Fierce Biotech
Fri, 11/20/15 - 06:20 pm
Takeda
Velcade
FDA
ixazomib
Multiple Myeloma
J&J nabs an early OK for 'breakthrough' multiple myeloma blockbuster contender Darzalex
Fierce Biotech
Mon, 11/16/15 - 03:29 pm
JNJ
Multiple Myeloma
daratumumab
FDA
Darzalex
Genmab
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
…
next ›
last »